AC Immune S.A. (ACIU) vs Fulcrum Therapeutics, Inc. (FULC)
A side-by-side comparison of AC Immune S.A. and Fulcrum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACIU
AC Immune S.A.
$2.71HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
FULC
Fulcrum Therapeutics, Inc.
$3.71HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACIU vs FULC
growth of $100 · dividends reinvested · last 7yACIU -51.4% (-9.8%/yr)FULC -72.5% (-16.8%/yr)ACIU compounded faster over this window
ACIU FULC
ACIU vs FULC: by the numbers
- •FULC is the larger company ($283M vs $276M market cap).
- •Both run net losses; FULC's is the smaller (0.00% vs -249.94% net margin).
Metrics side by side
Valuation
| Metric | ACIU | FULC |
|---|---|---|
| P/S ratio | 12.71 | N/A |
| P/B ratio | 6.34 | 0.91 |
Profitability
| Metric | ACIU | FULC |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -1927.32% | 0.00% |
| Net margin | -249.94% | 0.00% |
| ROE | -124.67% | -27.36% |
| ROIC | -89.43% | -27.62% |
Growth (annualized)
| Metric | ACIU | FULC |
|---|---|---|
| Revenue CAGR (5Y) | -23.70% | N/A |
| Total return CAGR (5Y) | -16.03% | -31.70% |
Frequently asked
- How have ACIU and FULC total returns compared?
- Over the past 5 years, ACIU delivered -16.03% and FULC delivered -31.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.